Finally, the anomalies of CD24 and CD38 expression on B cells cultured from ME/CFS patients and their links with metabolic reprogramming and MM may serve as an ideal model for the study of disruption of normal pathways for energy production in patients with ME/CFS. The gene discussed is CD24; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.